These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32050824)

  • 1. Semliki Forest virus-based immunotherapy for cancer.
    Lundstrom K
    Expert Opin Biol Ther; 2020 Jun; 20(6):593-599. PubMed ID: 32050824
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy.
    Zajakina A; Spunde K; Lundstrom K
    Curr Pharm Des; 2017; 23(32):4906-4932. PubMed ID: 28641531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and application of alphaviruses in gene therapy.
    Lundstrom K
    Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphavirus-based vaccines.
    Lundstrom K
    Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy.
    Riezebos-Brilman A; de Mare A; Bungener L; Huckriede A; Wilschut J; Daemen T
    J Clin Virol; 2006 Mar; 35(3):233-43. PubMed ID: 16448844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semliki Forest virus vectors for gene therapy.
    Lundstrom K
    Expert Opin Biol Ther; 2003 Aug; 3(5):771-7. PubMed ID: 12880377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphaviruses in cancer immunotherapy.
    Lundstrom K
    Int Rev Cell Mol Biol; 2023; 379():143-168. PubMed ID: 37541722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.
    Ren H; Boulikas T; Lundstrom K; Söling A; Warnke PC; Rainov NG
    J Neurooncol; 2003; 64(1-2):147-54. PubMed ID: 12952295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphavirus vectors for gene therapy applications.
    Lundstrom K
    Curr Gene Ther; 2001 May; 1(1):19-29. PubMed ID: 12109136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
    Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
    Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphaviruses in Immunotherapy and Anticancer Therapy.
    Lundstrom K
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.
    Colmenero P; Chen M; Castaños-Velez E; Liljeström P; Jondal M
    Int J Cancer; 2002 Apr; 98(4):554-60. PubMed ID: 11920615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavirus-Based Vaccines.
    Lundstrom K
    Methods Mol Biol; 2016; 1404():313-328. PubMed ID: 27076308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and prophylactic applications of alphavirus vectors.
    Atkins GJ; Fleeton MN; Sheahan BJ
    Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
    Yamanaka R; Zullo SA; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
    Neurosurg Focus; 2000 Dec; 9(6):e7. PubMed ID: 16817690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
    Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG
    J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
    Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphavirus vectors as tools in cancer gene therapy.
    Lundstrom K
    Technol Cancer Res Treat; 2002 Feb; 1(1):83-8. PubMed ID: 12614181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.
    Ballesteros-Briones MC; Martisova E; Casales E; Silva-Pilipich N; Buñuales M; Galindo J; Mancheño U; Gorraiz M; Lasarte JJ; Kochan G; Escors D; Sanchez-Paulete AR; Melero I; Prieto J; Hernandez-Alcoceba R; Hervas-Stubbs S; Smerdou C
    Mol Ther; 2019 Nov; 27(11):1892-1905. PubMed ID: 31563534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.